Cambridge Investment Research Advisors’s Altimmune ALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$72K Buy
18,668
+3,000
+19% +$11.6K ﹤0.01% 3508
2025
Q1
$78K Buy
15,668
+1,147
+8% +$5.71K ﹤0.01% 3378
2024
Q4
$105K Buy
14,521
+2,400
+20% +$17.4K ﹤0.01% 3320
2024
Q3
$74K Buy
+12,121
New +$74K ﹤0.01% 3298